APA

Manders P., Tjan-Heijnen V. C. G., Span P. N., Grebenchtchikov N., Geurts-Moespot A., van Tienoven D. T. H., Beex L. V. A. M. & Sweep F. C. G. J. (20040817). Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. : Cancer.

Chicago

Manders Peggy, Tjan-Heijnen Vivianne C G, Span Paul N, Grebenchtchikov Nicolai, Geurts-Moespot Anneke, van Tienoven Doorlène T H, Beex Louk V A M and Sweep Fred C G J. 20040817. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. : Cancer.

Harvard

Manders P., Tjan-Heijnen V. C. G., Span P. N., Grebenchtchikov N., Geurts-Moespot A., van Tienoven D. T. H., Beex L. V. A. M. and Sweep F. C. G. J. (20040817). Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. : Cancer.

MLA

Manders Peggy, Tjan-Heijnen Vivianne C G, Span Paul N, Grebenchtchikov Nicolai, Geurts-Moespot Anneke, van Tienoven Doorlène T H, Beex Louk V A M and Sweep Fred C G J. Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. : Cancer. 20040817.